Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data (Q31116375)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
scientific article

    Statements

    title
    Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data (English)
    1 reference
    stated in
    Europe PubMed Central
    PMC publication ID
    1994026
    retrieved
    11 August 2017
    main subject
    endocannabinoids
    0 references
    cardiovascular disease
    9 references
    stated in
    PubMed Central
    retrieved
    14 March 2019
    stated in
    PubMed
    retrieved
    19 March 2019
    stated in
    PubMed
    retrieved
    24 March 2019
    stated in
    PubMed
    retrieved
    20 June 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    stated in
    PubMed
    retrieved
    31 July 2019
    stated in
    PubMed
    retrieved
    20 August 2019
    stated in
    PubMed
    retrieved
    17 September 2019
    stated in
    PubMed
    retrieved
    15 December 2019
    diabetes
    9 references
    stated in
    PubMed Central
    retrieved
    14 March 2019
    stated in
    PubMed
    retrieved
    19 March 2019
    stated in
    PubMed
    retrieved
    24 March 2019
    stated in
    PubMed
    retrieved
    20 June 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    stated in
    PubMed
    retrieved
    31 July 2019
    stated in
    PubMed
    retrieved
    20 August 2019
    stated in
    PubMed
    retrieved
    17 September 2019
    stated in
    PubMed
    retrieved
    15 December 2019
    metabolic syndrome
    9 references
    stated in
    PubMed Central
    retrieved
    14 March 2019
    stated in
    PubMed
    retrieved
    19 March 2019
    stated in
    PubMed
    retrieved
    24 March 2019
    stated in
    PubMed
    retrieved
    20 June 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    stated in
    PubMed
    retrieved
    31 July 2019
    stated in
    PubMed
    retrieved
    20 August 2019
    stated in
    PubMed
    retrieved
    17 September 2019
    stated in
    PubMed
    retrieved
    15 December 2019
    obesity
    9 references
    stated in
    PubMed Central
    retrieved
    14 March 2019
    stated in
    PubMed
    retrieved
    19 March 2019
    stated in
    PubMed
    retrieved
    24 March 2019
    stated in
    PubMed
    retrieved
    20 June 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    stated in
    PubMed
    retrieved
    31 July 2019
    stated in
    PubMed
    retrieved
    20 August 2019
    stated in
    PubMed
    retrieved
    17 September 2019
    stated in
    PubMed
    retrieved
    15 December 2019
    cell surface receptor
    1 reference
    stated in
    PubMed
    retrieved
    31 July 2019
    physiological phenomenon
    1 reference
    stated in
    PubMed
    retrieved
    20 August 2019
    heterocyclic compound
    1 reference
    stated in
    PubMed
    retrieved
    17 September 2019
    membrane protein
    1 reference
    stated in
    PubMed
    retrieved
    15 December 2019
    cites work

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q31116375&oldid=1545530767"